News

Wrap Technologies, Inc. Gears Up for Q3 2025 Earnings Call

Wrap Technologies, Inc. Gears Up for Q3 2025 Earnings Call

Upcoming Conference Call for Financial Results

Wrap Technologies, Inc. (NASDAQ: WRAP), a prominent name in public safety technologies, is preparing for an engaging conference call to discuss its third-quarter financial results. Scheduled for November 12, 2025, at 4:30 p.m. Eastern Time, this call will provide investors and stakeholders with essential insights into the company's fiscal performance for the three months concluded on September 30, 2025.

Details of the Conference Call

The company will share its financial and operational results in a press release ahead of the call, allowing participants to come prepared for discussions. The management team at Wrap will not only present the results but will also engage in a question-and-answer session, promoting transparency and interaction between the company and its investors.

Submitting Questions

Investors interested in addressing questions during the call are encouraged to submit these inquiries in advance. Questions should be directed to the company via their Investor Relations email by 5:00 p.m. Eastern Time on November 10, 2025. The management will prioritize questions relevant to the company's strategic direction, execution, stockholder concerns, and public disclosure guidelines.

Wrap is known for its innovative solutions in the realm of public safety, reflecting their commitment to community-focused technology. With their BolaWrap® 150 device, they provide law enforcement agencies with a non-lethal tool designed to help manage critical incidents safely and effectively.

The BolaWrap® 150: A Game Changer in Law Enforcement

This unique device leverages a multi-sensory approach combining sight, sound, and sensation to allow law enforcement to engage individuals in a non-painful manner, giving officers a valuable advantage in pre-escalation scenarios. Used by more than 1,000 agencies and operational in over 60 countries, the BolaWrap® 150 is backed by robust training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST).

Comprehensive Training with Wrap Reality™ VR

In addition to the BolaWrap® 150, Wrap Technologies offers the Wrap Reality™ VR, an immersive training simulator designed to enhance decision-making during high-pressure situations. This platform provides first responders with interactive scenarios, fostering the skills needed to navigate complex encounters safely and effectively.

Efficiency of WrapVision

Wrap's commitment to innovation also shines through with WrapVision, an advanced body-worn camera system. This system is designed to meet the stringent demands of contemporary law enforcement, ensuring operational security and compliance while enhancing video quality. With cloud integration and domestic manufacturing, WrapVision guarantees data integrity and diminishes concerns related to unauthorized access.

Conclusion

As Wrap Technologies continues to advance its product offerings and solidify its position in the public safety sector, the impending earnings call represents an opportunity for stakeholders to grasp the company's progress and future direction. For those looking to gain insights into Wrap's operations and strategic initiatives, joining the conference call may be a valuable experience.

Frequently Asked Questions

What is the date and time of the earnings call?

The earnings call is scheduled for November 12, 2025, at 4:30 p.m. Eastern Time.

How can I submit questions for the call?

Questions can be submitted to ir@wrap.com by 5:00 p.m. Eastern Time on November 10, 2025.

What is the main product discussed in the article?

The BolaWrap® 150, a non-lethal device for law enforcement, is the primary focus of the article.

What training solutions does Wrap Technologies offer?

Wrap Technologies offers the Wrap Reality™ VR training simulator to improve decision-making skills for first responders.

How does WrapVision enhance law enforcement operations?

WrapVision improves efficiency, security, and compliance in managing digital evidence, ensuring better operational transparency.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 237

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 161

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 171

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 270

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Envoy Medical Advances Hearing Solutions with CPT Code Approval

Updated Category News Views 189

Envoy Medical Achieves Significant Milestone in Hearing Technology Envoy Medical, Inc. (NASDAQ: COCH), a trailblazer in the realm of fully implanted hearing devices, has reached an important juncture with the American Medical Association's (AMA) approval of five new CPT codes. This auspicious development is centered around the Esteem device, the only FDA-approved fully...

Continue Reading
McEwen Inc. Reports Q3 2025 Outcomes for Future Growth Goals

Updated Category News Views 136

Overview of McEwen Inc.'s Q3 2025 Performance McEwen Inc. (NYSE/TSX: MUX) has recently shared its operational and financial outcomes for the third quarter of 2025. This financial update highlights the company's ambitious plan to double its production by 2030. The goal is set at achieving consolidated annual production in the range of 250,000 to 300,000 Gold Equivalent...

Continue Reading
Investors of Rentokil Initial plc Take Action Against Alleged Fraud

Updated Category News Views 312

Understanding the Investor Challenge Investors often find themselves at a crossroads when facing potential losses in their portfolios. The situation is particularly concerning for those who acquired American Depositary Shares (ADS) of Rentokil Initial plc (NYSE: RTO) within the specified timeframe. Losses exceeding $100,000 can be a significant burden, prompting many to...

Continue Reading
Elevating Awareness: Tonix Pharmaceuticals' Campaign for Fibromyalgia

Updated Category News Views 190

Tonix Pharmaceuticals Launches the Move Fibro Forward Campaign Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a dedicated biotechnology company, has recently introduced the impactful campaign known as Move Fibro Forward. This initiative is aimed at shedding light on fibromyalgia, a chronic condition that has seen little advancement in treatment options over the past...

Continue Reading
SparDanmark Invest Temporarily Suspends Trading for All Classes

Updated Category News Views 128

Temporary Suspension of Trading at SparDanmark Invest Recently, Nykredit Portefølje Administration A/S made an important announcement regarding the suspension of trading for all departments managed under its oversight. The decision was rooted in technical difficulties that hindered the accurate calculation of the Net Asset Value (NAV). This temporary measure reflects a...

Continue Reading